Health
UK launches trial of drug to tackle fatigue in long Covid patients – The Guardian
AXA1125 targets cell power plants that may be dysfunctional in long Covid patients with severe fatigue
Long CovidAXA1125 targets cell power plants that may be dysfunctional in long Covid patients with severe fatigue
The first trial of a drug to target the fatigue and muscle weakness experienced by more than half of people with long Covid has been launched…
Continue Reading